BALAXI PHARMACEUTICALS LIMITED
NSE: BALAXI | Information Technology
Market Fundamentals
Stock Intelligence & News
BALAXI PHARMACEUTICALS LIMITED
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding 'RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended April 2026'. |SUBJECT: Updates
Read Full Analysis →BALAXI PHARMACEUTICALS LIMITED
Board Meeting Intimation |Meeting Date: 28-May-2026
Read Full Analysis →BALAXI PHARMACEUTICALS LIMITED
Financial Results/Other business matters |Meeting Date: 28-May-2026
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
BALAXI PHARMACEUTICALS LIMITED
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding '''RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended February 2026 and March 2026".'. |SUBJECT: Updates
Read Full Analysis →BALAXI PHARMACEUTICALS LIMITED
BALAXI PHARMACEUTICALS LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →BALAXI PHARMACEUTICALS LIMITED
Ashish Maheshwari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →BALAXI PHARMACEUTICALS LIMITED
Significant movement in price has been observed in BALAXI PHARMACEUTICALS LIMITED. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. BALAXI PHARMACEUTICALS LIMITED has submitted their response. |SUBJECT: Price movement
Read Full Analysis →BALAXI PHARMACEUTICALS LIMITED
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Credit Rating- Revision |SUBJECT: Credit Rating- Revision
Read Full Analysis →BALAXI PHARMACEUTICALS LIMITED
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →BALAXI PHARMACEUTICALS LIMITED
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →Get instant alerts when BALAXI breaks news
Join investors who track BALAXI PHARMACEUTICALS LIMITED on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for BALAXI?
BALAXI is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for BALAXI PHARMACEUTICALS LIMITED?
You can set real-time price and news alerts by registering on the Alerfo platform and adding BALAXI to your custom watchlist.